Skip to main content
SpringerLink
Log in

Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

In a 4-year controlled, prospective trial, histomorphometric analysis was used to compare the tissue-level skeletal effects of fluoride therapy in 43 postmenopausal women (75 mg NaF/day) with those of 35 matching placebo subjects; all subjects received 1500 mg/day elemental calcium supplement. In addition to an initial, baseline biopsy, a second biopsy was obtained after 6, 18, 30 or 48 months. Measurements were made on a third biopsy obtained from 8 subjects following at least 72 months of fluoride therapy. The change in cancellous bone volume or trabecular thickness in fluoride-treated subjects was not different from a change in placebo-treated subjects. However, paired analysis in the fluoride-treated subjects indicated that bone volume was increased between the first and second biopsies (p<0.005). Both osteoid length and width were significantly increased in fluoride compared with placebo subjects; however, only the osteoid surface increased linearly (r=0.63,p<0.001). The mineral apposition rate and relative tetracycline-covered bone surface were not different between fluoride and placebo treatment, although they were decreased in both groups in the second biopsy. The tetracycline-covered bone surface returned to normal in the third biopsy. Definitive evidence for osteomalacia is a prolonged mineralization lag time, which following fluoride treatment was found to be increased 9-fold in the second biopsy and 4-fold in the third biopsy. Further evidence for osteomalacia was increased osteoid thickness by 6 months, evidence of focal areas of interstitial mineralization defects, and broad tetracycline labels of low fluorescence intensity. In the third biopsies, osteoclastic resorption was observed beneath osteoid seams. Fluoride therapy increased the cortical width compared with placebo treatment (p<0.02), and increased the osteoid surface in Haversian canals, but did not change the osteoid width, resorption surface or cortical porosity. After an initial rise, serum fluoride levels remained constant, and the urine values fell slightly. The bone fluoride concentration rose throughout the treatment period, and was correlated with the change in osteoid-covered bone surface (r=0.56,p<0.001). Although we found definitive evidence for osteomalacia, the cause of the osteomalacia was not determined in this study. On the other hand, the presence of bone resorption beneath unmineralized osteoid and of osteocyte halos is suggestive of hyperparathyroidism. Thus, it is possible that the strong stimulus for bone formation brought about by fluoride therapy resulted in relative calcium deficiency.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rich C, Ensinck J. Effect of sodium fluoride on calcium metabolism of human beings. Nature 1961;191:184–5.

    Google Scholar 

  2. Jowsey J, Riggs BL, Kelly PJ, Hoffman DL. Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis. Am J Med 1972;53:43–9.

    Google Scholar 

  3. Ringe JD, Kruse HP, Kuhlencordt F. Long term treatment of primary osteoporosis by sodium fluoride. In: B. Courvoisier, A Donath, editors. Fluoride and bone. Bern: Hans Huber, 1978:228–32.

    Google Scholar 

  4. Vose GP, Keele DK, Milner AM, et al. Effect of sodium fluoride, inorganic phosphate, and oxymetholone therapies in osteoporosis: a six-year progress report. J Gerontol 1978;33:204–221.

    Google Scholar 

  5. Riggs BL, Seeman E, Hodgson SF, Taves DR, O'Fallon WM. Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. N Eng J Med 1982;306:446–50.

    Google Scholar 

  6. Dambacher MA, Ittner J, Ruegsegger P. Long-term fluoride therapy of postmenopausal osteoporosis. Bone 1986;7:199–205.

    Google Scholar 

  7. Hansson T, Roos B. The effect of fluoride and calcium on spinal bone mineral content: a controlled, prospective (3 years) study. Calcif Tissue Int 1987;40:315–7.

    Google Scholar 

  8. Briancon D, Meunier PJ. Treatment of osteoporosis with fluoride, calcium and vitamin D. Orthop Clinic North Am 1981;12:629–48.

    Google Scholar 

  9. Lane JM, Healey JH, Schwartz E, Vigorita VJ, Schneider R, Einhorn TA, et al. Treatment of osteoporosis with sodium fluoride and calcium: effects on vertebral fracture incidence and bone histomorphometry. Orthop Clin North Am 1984;15:729–45.

    Google Scholar 

  10. Eriksen EF, Mosekilde L, Melsen F. Effect of sodium fluoride, calcium, phosphate, and vitamin D2 on trabecular bone balance and remodeling in osteoporotics. Bone 1985;6:381–9.

    Google Scholar 

  11. Harrison JE, Bayley TA, Josse RG, Murray TM, Sturtridge W, Williams C, et al. The relationship between fluoride effects on bone histology and on bone mass in patients with postmenopausal osteoporosis. Bone Miner 1986;1:231–33.

    Google Scholar 

  12. Farley JR, Wergedal JE, Baylink DJ. Fluoride directly stimulates proliferation and alkaline phosphatase activity of bone-forming cells. Science 1982;222:330–1.

    Google Scholar 

  13. Riggs BL, Hodgson SF, O'Fallon WM, Chao EYS, Wahner HW, Muhs JM, et al. The effect of fluoride treatment on vertebral fracture rate in osteoporotic women. N Engl J Med 1990;322:802–9.

    Google Scholar 

  14. Riggs BL, O'Fallon WM, Lane A, Hodgson SF, Wahner HW, Muhs J, et al. Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extended observations and additional analysis. J Bone Miner Res 1994;9:265–75.

    Google Scholar 

  15. Nagent de Deuxchaisnes C, Devogelaer JP, Stein F. Fluoride treatment for osteoporosis. Lancet 1990;336:49–50.

    Google Scholar 

  16. Gruber HE, Stauffer ME, Thompson ER, Baylink DJ. Diagnosis of bone disease by core biopsies. Semin Hematol 1981;18:258–78.

    Google Scholar 

  17. Evans RA, Dunstan CR, Baylink DJ. Histochemical identification of osteoclasts in undecalcified sections of human bone. Miner Electrolyte Metab 1979;2:179–85.

    Google Scholar 

  18. Gruber HE, Ivey JL, Baylink DJ. Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism 1984;33:295–303.

    Google Scholar 

  19. Parfitt AM, Drezner ML, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. J Bone Miner Res 1987;2:595–610.

    Google Scholar 

  20. Fry BW, Taves DR. Serum fluoride analysis with the fluoride electrode. J Lab Clin Med 1970;75:1020–5.

    Google Scholar 

  21. Charen J, Taves DR, Stamm JW, Parkins FM. Bone fluoride concentrations associated with fluoridated drinking water. Calcif Tiss Int 1979;27:95–9.

    Google Scholar 

  22. Altman DG. Practical statistics for medical research. New York: Chapman & Hall, 1991:211.

    Google Scholar 

  23. Podenphant J, Riis BJ, Johansen JS, Leth A., Christiansen C. Iliac crest biopsy in longitudinal therapeutic trials of osteoporosis. Bone Miner 1988;5:77–87.

    Google Scholar 

  24. Kleerekoper M, Balena R, Foldes J, Shih M-S, Rao D, Parfitt AM. Histomorphometric changes in iliac bone induced by sodium fluoride (NAF) therapy depend on cumulative dose. J Bone Miner Res 1990;5(Suppl 2):S140.

    Google Scholar 

  25. Budden FH, Bayley TA, Harrison JE, Josse RG, Murray TM, Sturtridge WS, et al. The effect of fluoride on bone histology in postmenopausal osteoporosis depends on adequate fluoride absorption and retention. J Bone Miner Res 1988;3:127–32.

    Google Scholar 

  26. Hodsman AB, Droost DJ. The response of vertebral bone mineral density during the treatment of osteoporosis with sodium fluoride. J Clin Endocrinol Metab 1989;69:932–8.

    Google Scholar 

  27. Boivin G, Chapuy M-C, Baud CA, Meunier PJ. Fluoride content in human iliac bone: results in controls, patients with fluorosis, and osteoporotic patients treated with fluoride. J Bone Miner Res 1988;3:497–502.

    Google Scholar 

  28. Boivin G, Duriez J, Chapuy M-C, Flautre B, Hardouin P, Meunier PJ. Relationship between bone fluoride content and histological evidence of calcification defects in osteoporotic women treated long term with sodium fluoride. Osteoporosis Int 1993;3:204–8.

    Google Scholar 

  29. Meunier PJ, Briancon D, Chavassieux P, et al. Treatment with fluoride: bone histomorphometric findings. In: Christiansen C, Johansen JS, Riis BJ, editors. Osteoporosis. Viborg: Norhave A/S, 1987;824–8.

    Google Scholar 

  30. Glimcher MJ. The nature of the mineral component of bone and the mechanism of calcification. In: Avioli LV, Krane SM, editors. Metabolic bone disease and clinically related disorders. Philadelphia: WB Saunders, 1990:42–68.

    Google Scholar 

  31. Harrison JE, Hitchman AJ, Hitchman A, Hasany SA. Fluoride inhibition of bone mineralization may depend on physical/chemical properties. Bone Miner 1988;4:37–47.

    Google Scholar 

  32. Harrison JE, Hitchman AJW, Hasany SA, Hitchman A. Tam CS. The effect of fluoride on nephrocalcinosis in rats. Clin Biochem 1983;18:109–13.

    Google Scholar 

  33. Malluche HH, Faugere MC. Atlas of mineralized bone histology. Basel: Karger, 1986:60–3, 70–87.

    Google Scholar 

  34. Teotia SPS, Teotia M. Secondary hyperparathyroidism in patients with endemic skeletal fluorosis. BMJ 1973;1:637–40.

    Google Scholar 

  35. Srivastava RN, Gill DS, Moudgil A, Menon RJ, Thomas M, Dandona P. Normal ionized calcium, parathyroid hypersecretion, and elevated osteocalcin in a family with fluorosis. Metabolism 1989;38:120–4.

    Google Scholar 

  36. Yates C, Doty S, Talmadge RV. Effects of sodium fluoride on calcium homeostasis. Proc Soc Expv Biol Med 1964;115:1103–9.

    Google Scholar 

  37. Faccini JM. Inhibition of bone resportion in the rabbit by fluoride. Nature 1967;214:1269–71.

    Google Scholar 

  38. Ream LJ, Principato R. Fluoride stimulation of the rat parathyroid gland: an ultrastructural study. Am J Anat 1981;162:233–41.

    Google Scholar 

  39. Rosenquist JB, Lorentzen PR, Boquist LLV. Effect of fluoride on parathyroid of normal and calcium deficient rats. Calcif Tissue Int 1983;35:533–7.

    Google Scholar 

  40. Andersen L, Richards A, Care AD, Kerzel Andersen HM, Kragstrup J, Fejerskov O. Parathyroid glands, calcium, and vitamin D in experimental fluorosis in pigs. Calcif Tissue Int 1986;38:222–6.

    Google Scholar 

  41. Kleerekoper M, Peterson E, Nelson DA, Phillips E, Schorck MA, Tilley BC, Parfitt AM. A randomized trial of sodium fluoride as a treatment for post-menopausal osteoporosis. Osteoporosis Int 1991;1:155–62.

    Google Scholar 

  42. Kleerekoper M, Mendlovic DB. Sodium fluoride therapy of postmenopausal osteoporosis. Endocr Rev 1993;14:312–23.

    Google Scholar 

  43. Grynpas MD. Fluoride effects on bone crystals. J Bone Miner Res 1990;5(Suppl 1):S169–75.

    Google Scholar 

  44. Wolinsky I, Simkin A, Guggenheim K. Effects of fluoride on metabolism and mechanical properties of rat bone. Am J Physiol 1972;223:46–50.

    Google Scholar 

  45. Rich C, Feist E. The action of fluoride on bone. In: Vischer VL, editor. Fluoride in medicine. Bern: Hans Huber, 1970:70–87.

    Google Scholar 

  46. Wolinsky I, Guggenheim DY. The effect of fluoride on the mechanical strength of bone. Baroda J Nutr 1976;3:177–88.

    Google Scholar 

  47. Riggins RS, Rucker RC, Chan MM, Zeman F, Beljan JR. The effect of fluoride supplementation on the strength of osteopenic bone. Clin Orthop 1976;114:352–7.

    Google Scholar 

  48. Parfitt AM. Osteomalacia and related disorders. In: Avioli LV, Krane SM, editors. Metabolic bone disease and clinically related disorders, 2nd ed. Philadelphia: WB Saunders, 1990:329–96.

    Google Scholar 

  49. Dure-Smith BA, Farley SM, Linkhart SG, Baylink DJ. Fluoride treated patients become calcium deficient despite calcium supplements: correction with 1,25 vitamin D3. In: Christiansen C, Riis B, editors. Proceedings of the Fourth International Symposium on Osteoporosis 1993. Aalborg, Denmark: Handelstrykkeriet AalborgApS, 1993:146–7.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pettis Veterans Hospital, Loma Linda, California

    M. W. Lundy PhD, M. Stauffer, J. E. Wergedal & D. J. Baylink

  2. Eastman Dental Center, Rochester, New York

    J. D. B. Featherstone

  3. Mayo Clinic, Rochester, Minnesota, USA

    S. F. Hodgson & B. L. Riggs

Authors
  1. M. W. Lundy PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Stauffer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. E. Wergedal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. J. Baylink
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. D. B. Featherstone
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. F. Hodgson
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B. L. Riggs
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lundy, M.W., Stauffer, M., Wergedal, J.E. et al. Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects. Osteoporosis Int 5, 115–129 (1995). https://doi.org/10.1007/BF01623313

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01623313

Keywords

Search

Navigation